P1558: EARLY-START DEFERIPRONE IN INFANTS/YOUNG CHILDREN WITH TRANSFUSION-DEPENDENT BETA THALASSEMIA: EVIDENCE FOR IRON SHUTTLING TO TRANSFERRIN—RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (START)

• F. Tricta,
• C. Fradette,
• N. Temin,
• A. Rozova,
• D. Lee,
• I. Cabantchik

Affiliations

F. Tricta

1 Chiesi Canada Corporation, Toronto, Canada

C. Fradette

1 Chiesi Canada Corporation, Toronto, Canada

N. Temin

1 Chiesi Canada Corporation, Toronto, Canada

A. Rozova

1 Chiesi Canada Corporation, Toronto, Canada

D. Lee

1 Chiesi Canada Corporation, Toronto, Canada

I. Cabantchik

2 Alexander Silberman Institute of Life Sciences, Jerusalem, Israel